ACXP
Price
$4.82
Change
+$0.10 (+2.12%)
Updated
Aug 25, 11:43 AM (EDT)
Capitalization
7.47M
85 days until earnings call
CERO
Price
$8.13
Change
-$0.17 (-2.05%)
Updated
Aug 25, 10:30 AM (EDT)
Capitalization
10M
Interact to see
Advertisement

ACXP vs CERO

Header iconACXP vs CERO Comparison
Open Charts ACXP vs CEROBanner chart's image
Acurx Pharmaceuticals
Price$4.82
Change+$0.10 (+2.12%)
Volume$100
Capitalization7.47M
CERO Therapeutics Holdings
Price$8.13
Change-$0.17 (-2.05%)
Volume$528
Capitalization10M
ACXP vs CERO Comparison Chart in %
Loading...
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACXP vs. CERO commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a Hold and CERO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (ACXP: $4.72 vs. CERO: $8.30)
Brand notoriety: ACXP and CERO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 50% vs. CERO: 10%
Market capitalization -- ACXP: $7.47M vs. CERO: $10M
ACXP [@Biotechnology] is valued at $7.47M. CERO’s [@Biotechnology] market capitalization is $10M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 1 FA rating(s) are green whileCERO’s FA Score has 1 green FA rating(s).

  • ACXP’s FA Score: 1 green, 4 red.
  • CERO’s FA Score: 1 green, 4 red.
According to our system of comparison, CERO is a better buy in the long-term than ACXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 6 TA indicator(s) are bullish while CERO’s TA Score has 3 bullish TA indicator(s).

  • ACXP’s TA Score: 6 bullish, 4 bearish.
  • CERO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACXP is a better buy in the short-term than CERO.

Price Growth

ACXP (@Biotechnology) experienced а -7.73% price change this week, while CERO (@Biotechnology) price change was +3.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.14%. For the same industry, the average monthly price growth was +19.96%, and the average quarterly price growth was +30.79%.

Reported Earning Dates

ACXP is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CERO($10M) has a higher market cap than ACXP($7.47M). ACXP YTD gains are higher at: -71.038 vs. CERO (-93.083). CERO has higher annual earnings (EBITDA): -8.49M vs. ACXP (-10.05M). ACXP has more cash in the bank: 6.06M vs. CERO (5.2M). ACXP has less debt than CERO: ACXP (66.5K) vs CERO (1.37M). ACXP (0) and CERO (0) have equivalent revenues.
ACXPCEROACXP / CERO
Capitalization7.47M10M75%
EBITDA-10.05M-8.49M118%
Gain YTD-71.038-93.08376%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.06M5.2M117%
Total Debt66.5K1.37M5%
TECHNICAL ANALYSIS
Technical Analysis
ACXPCERO
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
11%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
47%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
32%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
26%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 19 days ago
55%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
22%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLMN7.360.40
+5.82%
Bloomin' Brands
SVII12.340.34
+2.83%
Spring Valley Acquisition Corp
APRE1.640.04
+2.81%
Aprea Therapeutics
MANU17.510.32
+1.86%
Manchester United PLC
QSR63.40-0.39
-0.61%
Restaurant Brands International

CERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERO has been loosely correlated with UNCY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CERO jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
N/A
UNCY - CERO
37%
Loosely correlated
-1.18%
UTHR - CERO
34%
Loosely correlated
+0.51%
ACXP - CERO
33%
Loosely correlated
+3.63%
BRTX - CERO
30%
Poorly correlated
+1.34%
LQDA - CERO
26%
Poorly correlated
-1.68%
More